Precigen (PGEN) 2025 Earnings Outlook: What to Watch
As biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
Stay vigilant for fake initial coin offerings by examining whitepapers, token metrics, and regulatory disclosures to prevent losses.
17,900 articlesAs biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
Bitcoin briefly topped $80,000 again as traders weigh whether the move signals real demand or a looming reversal. Ana...
A deep-dive look at electroCore's 2026 earnings narrative. This article unpacks Q1 signals, growth drivers, and pract...
Radian Group's Q1 2026 earnings narrative reveals how the mortgage insurance business is performing, how risk is mana...
Eli Lilly's ascent to the top of the drug charts centers on a single family of medicines. This article breaks down wh...
A new wave of demand for Palantir’s AI-powered data platforms could reshape its five-year trajectory. This guide brea...
When bad news hits a stock, investors ask if it’s a bargain. This piece weighs UPS’s challenges against its resilient...
As 2026 unfolds, Resideo's earnings trajectory blends hardware sales with growing recurring revenue. This guide break...
Investors are watching Paysign as it tees up Q1 2026 earnings. This article breaks down what to expect, key metrics t...
Maze Therapeutics stock still faces mixed signals from the market: a strong rally after a March dip, paired with a no...
Nike stands as a global powerhouse, but recent pressure has investors asking, should Nike stock? This guide lays out ...
As TJX prepares for the (tjx) 2027 earnings call, investors are weighing store growth, margins, and online evolution....